glucagon has been researched along with Critical Illness in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derde, S; Derese, I; Dufour, T; Goossens, C; Holst, JJ; Langouche, L; Peersman, N; Thiessen, SE; Van den Berghe, G; Vander Perre, S; Vanhorebeek, I; Vega, CA; Vermeersch, P; Wouters, PJ | 1 |
| Preiser, JC; Wernerman, J | 1 |
| Gunst, J; Thiessen, SE; Van den Berghe, G | 1 |
| Bonikowska, K; Magnusson, P; Sjöholm, Å | 1 |
| Annink, CE; Chapman, MJ; Cousins, CE; Deane, AM; Horowitz, M; Jones, KL; Kar, P; Meier, JJ; Nauck, MA | 1 |
| Besanko, LK; Burgstad, CM; Chapman, MJ; Deane, AM; Fraser, RJ; Horowitz, M | 1 |
| Chapman, MJ; Deane, AM; Fraser, RJ; Horowitz, M; Jones, KL; Rayner, CK; Storey, JP; Summers, MJ; Zaknic, AV | 1 |
| Baxter, R; Brugts, M; Coopmans, W; Gielen, M; Janssen, JA; Lamberts, S; Mesotten, D; Van den Berghe, G; Van Herck, E; Vanhorebeek, I | 1 |
| Deane, AM; Horowitz, M | 1 |
| Chevrolet, JC; Genton, L; Graf, JD; Jolliet, P; Kyle, UG; Meier, CA; Mensi, N; Pichard, C | 1 |
| Berger, MM; Chioléro, R; Kim, S; Revelly, JP; Schneiter, P; Schwarz, JM; Tappy, L | 1 |
| Cao, XY; Ding, H; He, LJ; Liu, M; Ma, SL; Ma, XG; Ma, XW; Wang, XH; Wang, XQ; Yang, XJ | 1 |
| de Boer, H; Groeneveld, AB; Nauta, JP; Strack van Schijndel, RJ; Thijs, LG; Voerman, BJ | 1 |
| Gore, DC; Jahoor, F | 1 |
| Ahnefeld, FW; Anhäupl, T; Ensinger, H; Geisser, W; Georgieff, M; Träger, K; Vogt, J | 1 |
| Gore, DC; Herndon, DN; Jahoor, F; Wolfe, RR | 1 |
2 review(s) available for glucagon and Critical Illness
| Article | Year |
|---|---|
Role of glucagon in protein catabolism.
Topics: Adaptation, Physiological; Amino Acids; Critical Illness; Feedback; Glucagon; Gluconeogenesis; Humans; Muscular Atrophy | 2018 |
Dysglycaemia in the critically ill - significance and management.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Critical Illness; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Risk Factors | 2013 |
6 trial(s) available for glucagon and Critical Illness
| Article | Year |
|---|---|
Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
Topics: Adult; Aged; Critical Illness; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptides; Glucose; Humans; Hyperglycemia; Hypoglycemia; Infusions, Intravenous; Insulin; Male; Middle Aged; Prospective Studies | 2015 |
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Critical Illness; Cross-Over Studies; Double-Blind Method; Enteral Nutrition; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Incretins; Infusions, Intravenous; Insulin; Male; Middle Aged | 2009 |
Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
Topics: 3-O-Methylglucose; Blood Glucose; Breath Tests; Critical Illness; Cross-Over Studies; Double-Blind Method; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Intensive Care Units; Respiration, Artificial | 2010 |
Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
Topics: Adolescent; C-Peptide; Case-Control Studies; Child; Child, Preschool; Critical Illness; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Infant; Infant, Newborn; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Intensive Care Units, Pediatric; Male; Prospective Studies | 2011 |
Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients.
Topics: Adult; Aged; Blood Glucose; Critical Care; Critical Illness; Energy Metabolism; Fat Emulsions, Intravenous; Fatty Acids, Omega-3; Female; Food, Fortified; Glucagon; Gluconeogenesis; Humans; Hydrocortisone; Insulin Resistance; Intensive Care Units; Lipid Metabolism; Liver; Male; Middle Aged; Parenteral Nutrition, Total | 2006 |
Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial.
Topics: Blood Glucose; C-Peptide; Critical Illness; Double-Blind Method; Energy Metabolism; Glucagon; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Lipids; Methylhistidines; Minerals; Nitrogen; Oxygen Consumption; Prospective Studies | 1995 |
8 other study(ies) available for glucagon and Critical Illness
| Article | Year |
|---|---|
Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition.
Topics: Aged; Amino Acids; Animals; Blood Glucose; Critical Illness; Disease Models, Animal; Female; Glucagon; Glucose; Humans; Insulin; Male; Mice; Middle Aged; Muscular Atrophy; Parenteral Nutrition; Treatment Outcome | 2017 |
Provision of Nutrients to the Acutely Ill. Introducing the "Baby Stomach" Concept.
Topics: Critical Illness; Glucagon; Humans; Parenteral Nutrition | 2017 |
[Life-threatening ketoacidosis in patients with type 2 diabetes on LCHF diet].
Topics: Adult; Critical Illness; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diet, Ketogenic; Glucagon; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
Clinical evaluation of hormonal stress state in medical ICU patients: a prospective blinded observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Critical Illness; Female; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Logistic Models; Male; Middle Aged; Pilot Projects; Prospective Studies; Single-Blind Method; Somatomedins; Statistics, Nonparametric; Stress, Physiological | 2005 |
[Study of relationship between stress hyperglycemia and insulin-resistance related factors].
Topics: Adult; Aged; C-Peptide; Critical Illness; Female; Glucagon; Humans; Hydrocortisone; Hyperglycemia; Insulin; Insulin Resistance; Intensive Care Units; Male; Middle Aged; Stress, Physiological; Tumor Necrosis Factor-alpha; Young Adult | 2006 |
Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers.
Topics: Acute Disease; Adaptation, Physiological; Adult; Burns; Case-Control Studies; Chronic Disease; Critical Illness; Epinephrine; Glucagon; Glutamine; Humans; Hydrocortisone; Intracellular Fluid; Male; Metabolic Clearance Rate; Muscles; Stress, Physiological | 1994 |
Glucose and urea production and leucine, ketoisocaproate and alanine fluxes at supraphysiological plasma adrenaline concentrations in volunteers.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; C-Peptide; Caproates; Critical Illness; Epinephrine; Gas Chromatography-Mass Spectrometry; Glucagon; Gluconeogenesis; Humans; Infusions, Intravenous; Insulin; Keto Acids; Leucine; Liver; Male; Metabolic Clearance Rate; Oxygen Consumption; Proteins; Time Factors; Urea | 1994 |
Acute response of human muscle protein to catabolic hormones.
Topics: Adult; Critical Illness; Epinephrine; Glucagon; Humans; Hydrocortisone; Lysine; Male; Muscle Proteins; Muscles; Stress, Physiological | 1993 |